FGFR2 overexpression predicts survival outcome in patients with metastatic papillary renal cell carcinoma

被引:0
|
作者
I. Tsimafeyeu
A. Khasanova
E. Stepanova
M. Gordiev
D. Khochenkov
A. Naumova
I. Varlamov
A. Snegovoy
L. Demidov
机构
[1] Kidney Cancer Research Bureau,
[2] Tatarstan Regional Cancer Center,undefined
[3] N.N. Blokhin Russian Cancer Research Center,undefined
[4] Altai Regional Cancer Center,undefined
来源
关键词
FGFR2; Overexpression; Mutations; Papillary renal cell carcinoma; Overall survival;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:265 / 268
页数:3
相关论文
共 50 条
  • [1] FGFR2 overexpression predicts survival outcome in patients with metastatic papillary renal cell carcinoma
    Tsimafeyeu, I.
    Khasanova, A.
    Stepanova, E.
    Gordiev, M.
    Khochenkov, D.
    Naumova, A.
    Varlamov, I.
    Snegovoy, A.
    Demidov, L.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (02): : 265 - 268
  • [2] FGFR2 expression to predict survival outcome in patients with metastatic papillary renal cell carcinoma.
    Tsimafeyeu, Ilya
    Naumova, Alexandra
    Stepanova, Evgenia
    Khasanova, Alfia
    Varlamov, Ilya
    Wynn, Nigel
    Snegovoy, Anton
    Demidov, Lev V.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [3] FGFR2 expression and mutation are rare in papillary renal cell carcinoma
    Tsimafeyeu, Ilya V.
    Wynn, Nigel
    Gordiyev, Marat
    Khasanova, Alfia
    CANCER RESEARCH, 2013, 73 (08)
  • [4] Overexpression of fibroblast growth factor receptors FGFR1 and FGFR2 in renal cell carcinoma
    Tsimafeyeu, Ilya
    Demidov, Lev
    Stepanova, Eugenia
    Wynn, Nigel
    Ta, Hung
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2011, 45 (03): : 190 - 195
  • [5] Treatment outcome for metastatic papillary renal cell carcinoma patients
    Rormen, Ellen A.
    Kondagunta, G. Varuni
    Ishill, Nicole
    Spodek, Lesley
    Russo, Paul
    Reuter, Victor
    Bacik, Jennifer
    Motzer, Robert J.
    CANCER, 2006, 107 (11) : 2617 - 2621
  • [6] Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma
    Vasselli, JR
    Yang, JC
    Linehan, WM
    White, DE
    Rosenberg, SA
    Walther, MM
    JOURNAL OF UROLOGY, 2001, 166 (01): : 68 - 72
  • [7] Overexpression of FGFR2 gene is associated with advanced stage squamous cell carcinoma of the lung
    Kikuchi, Ryutaro
    Huang, Cheng-long
    Miyahara, Ryo
    Sonobe, Makoto
    Menju, Toshi
    Kobayashi, Masashi
    Ishikawa, Masashi
    Kitamura, Jiro
    Date, Hiroshi
    CANCER RESEARCH, 2011, 71
  • [8] FGFR2 in gastric cancer: protein overexpression predicts gene amplification and high H-index predicts poor survival
    Ahn, Soomin
    Lee, Jeeyun
    Hong, Mineui
    Kim, Seung Tae
    Park, Se Hoon
    Choi, Min Gew
    Lee, Jun-Ho
    Sohn, Tae Sung
    Bae, Jae Moon
    Kim, Sung
    Jung, Sin-Ho
    Kang, Won Ki
    Kim, Kyoung-Mee
    MODERN PATHOLOGY, 2016, 29 (09) : 1095 - 1103
  • [9] A five-gene signature predicts overall survival of patients with papillary renal cell carcinoma
    Gao, Ze
    Zhang, Dong
    Duan, Yi
    Yan, Lei
    Fan, Yidong
    Fang, Zhiqing
    Liu, Zhaoxu
    PLOS ONE, 2019, 14 (03):
  • [10] Incidence of FGFR2 Amplification and FGFR2 Fusion in Patients with Metastatic Cancer Using Clinical Sequencing
    Hyung, Sujin
    Han, Boram
    Jung, Jaeyun
    Kim, Seung Tae
    Hong, Jung Yong
    Park, Se Hoon
    Zang, Dae Young
    Park, Joon Oh
    Park, Young Suk
    Kim, Kyoung-Mee
    Kang, Won Ki
    Lee, Jeeyun
    JOURNAL OF ONCOLOGY, 2022, 2022